Physician profile
Daniel Jay Zeppelin
NPI 1811016785
$1,929.45
in general payments reported to CMS, 2019-2025
13 companies · $290 in 2025
The $290 reported for 2025 was more than what 82% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $189 · 2021: $364 · 2022: $122 · 2023: $175 · 2024: $365 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $833.24 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Dentsply Sirona INC | $291.28 | 2019-2024 | Suresmile, Cerec |
| Straumann USA LLC | $267.25 | 2021-2024 | |
| Orapharma, A Division of Bausch Health US, LLC | $121.39 | 2019-2023 | Ossix Plus, Arestin |
| Ortho Organizers, INC. | $99.49 | 2025 | Carriere |
| Align Technology, INC. | $84.43 | 2019-2021 | |
| Septodont INC. | $72.93 | 2020 | |
| 3m Company | $45.99 | 2019 | |
| Kulzer, LLC | $30.77 | 2019 | |
| Envista Holdings Corporation | $28.87 | 2025 | Herculite Ultra |
| Keystone Dental INC. | $21.30 | 2019 | |
| Solventum Corporation | $19.71 | 2025 | Filtek, 3m Clinpro, Clarity Advanced |
| Scican INC | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Zeppelin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.